Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5127]
News [14850]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
Novel bi-specific TCR-based reagents for targeted cancer immunotherapy
Dr Joseph Dukes - Immunocore Limited, Abingdon, UK
Novel bi-specific TCR-based reagents for targeted cancer immunotherapy ( Dr Joseph Dukes - Immunocore Limited, Abingdon, UK )
27 Apr 2017
Discovering genes in mammary cancer by insertional mutagenesis
Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands
Discovering genes in mammary cancer by insertional mutagenesis ( Dr John Hilkens - Netherlands Cancer Institute, Amsterdam, Netherlands )
27 Apr 2017
Diagnosing cancerous and precancerous oesophageal disease
Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK
Diagnosing cancerous and precancerous oesophageal disease ( Prof Rebecca Fitzgerald - University of Cambridge, Cambridge, UK )
27 Apr 2017
Centrosomes in ovarian cancer
Dr Fanni Gergely - CRUK Cambridge Institute
Centrosomes in ovarian cancer ( Dr Fanni Gergely - CRUK Cambridge Institute )
27 Apr 2017
Genome stability in potentially immortal planarian stem cells
Sounak Sahu - University of Oxford, Oxford, UK
Genome stability in potentially immortal planarian stem cells ( Sounak Sahu - University of Oxford, Oxford, UK )
27 Apr 2017
Hallmarks of cancer cell development
Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne...
Hallmarks of cancer cell development ( Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland )
27 Apr 2017
Global horizons of the WIN consortium
Dr Vladimir Lazar - Chief Operating Officer, WIN Consortium
Global horizons of the WIN consortium ( Dr Vladimir Lazar - Chief Operating Officer, WIN Consortium )
27 Apr 2017
What is the WIN Consortium?
Dr John Mendelsohn - Chairman of the WIN Consortium
What is the WIN Consortium? ( Dr John Mendelsohn - Chairman of the WIN Consortium )
27 Apr 2017
Pembrolizumab and indoximod for melanoma
Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of...
Pembrolizumab and indoximod for melanoma ( Prof Yousef Nabih Zakharia - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA )
13 Apr 2017
Projections of cancer incidence and burden among the HIV-positive population in...
Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA
Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030 ( Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA )
12 Apr 2017
Nivolumab for NSCLC: five years on
Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Nivolumab for NSCLC: five years on ( Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
12 Apr 2017
Nivolumab and ipilimumab combination for advanced skin cancer
Dr James Larkin - The Royal Marsden, London, UK
Nivolumab and ipilimumab combination for advanced skin cancer ( Dr James Larkin - The Royal Marsden, London, UK )
12 Apr 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation